Hasan Zain Syed sold $917 of HIT
Hasan Zain Syed (Chief Growth Officer) sold 1,667 shares of Health In Tech, Inc. (HIT) at $0.55 on 2026-11-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to move the stock materially.
Market read
A routine insider sale with limited market impact.
What to watch
The insider still holds a large position, and the transaction was pre‑arranged under a 10b5‑1 plan.
Background
Form 4 filings disclose insider transactions; small sales by executives are common and often pre‑planned.
Ticker impact
Chief Growth Officer Hasan Zain Syed sold 1,667 shares for $917 via a 10b5‑1 plan, reducing his stake to 171,993 shares.
likely slight pressure as the market prices in the insider sale.
The sale is small relative to the company's float and does not signal a material change in outlook.
Market effects
none
none
none
Counterpoint
The sale could be a routine portfolio rebalancing and not indicative of negative sentiment.
Key entities
- companyHealth In Tech, Inc.
Issuer of the Form 4 filing.
- personHasan Zain Syed
Chief Growth Officer and reporting insider.
